<?xml version="1.0" encoding="UTF-8"?>
<p>Subsequent small randomised placebo-controlled clinical trials in critical limb ischaemia showed favourable results of intramuscular autologous bone marrow-derived MSC therapy compared with standard care in patients with non-healing ulcers.
 <xref rid="R29" ref-type="bibr">29 30</xref> MSC injection was more effective than mononuclear cell (MNCs) injection in critical limb ischaemia and non-healing ulcers of patients with diabetes, which confirms results from preclinical studies.
 <xref rid="R31" ref-type="bibr">31 32</xref>
</p>
